SE8804570L - Ciclosporinkristallform, foerfarande foer dess framstaellning, farmaceutiska kompositioner innehaallande densamma samt dess anvaendning - Google Patents

Ciclosporinkristallform, foerfarande foer dess framstaellning, farmaceutiska kompositioner innehaallande densamma samt dess anvaendning

Info

Publication number
SE8804570L
SE8804570L SE8804570A SE8804570A SE8804570L SE 8804570 L SE8804570 L SE 8804570L SE 8804570 A SE8804570 A SE 8804570A SE 8804570 A SE8804570 A SE 8804570A SE 8804570 L SE8804570 L SE 8804570L
Authority
SE
Sweden
Prior art keywords
crystal form
pharmaceutical compositions
ciclosporine
procedure
preparation
Prior art date
Application number
SE8804570A
Other languages
Unknown language ( )
English (en)
Other versions
SE503174C2 (sv
SE8804570D0 (sv
Inventor
D Giron
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8804570D0 publication Critical patent/SE8804570D0/sv
Publication of SE8804570L publication Critical patent/SE8804570L/sv
Publication of SE503174C2 publication Critical patent/SE503174C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SE8804570A 1987-12-21 1988-12-19 Ciclosporinkristallformer, förfarande för dess framställning, farmaceutiska kompositioner innehållande densamma samt dess användning SE503174C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28

Publications (3)

Publication Number Publication Date
SE8804570D0 SE8804570D0 (sv) 1988-12-19
SE8804570L true SE8804570L (sv) 1989-06-22
SE503174C2 SE503174C2 (sv) 1996-04-15

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8804570A SE503174C2 (sv) 1987-12-21 1988-12-19 Ciclosporinkristallformer, förfarande för dess framställning, farmaceutiska kompositioner innehållande densamma samt dess användning

Country Status (27)

Country Link
JP (1) JPH0791316B2 (sv)
KR (1) KR100188305B1 (sv)
AT (1) AT403163B (sv)
AU (1) AU626274B2 (sv)
BE (1) BE1002665A4 (sv)
CA (1) CA1341396C (sv)
CH (1) CH677926A5 (sv)
CY (1) CY1799A (sv)
DE (1) DE3843054C2 (sv)
DK (1) DK175220B1 (sv)
ES (1) ES2012580A6 (sv)
FI (1) FI89065C (sv)
FR (1) FR2624863B1 (sv)
GB (1) GB2211848B (sv)
GR (1) GR1002486B (sv)
HK (1) HK102894A (sv)
HU (1) HU203564B (sv)
IE (1) IE62006B1 (sv)
IL (1) IL88719A0 (sv)
IT (1) IT1235356B (sv)
LU (1) LU87409A1 (sv)
MY (1) MY103943A (sv)
NL (1) NL195096C (sv)
NO (1) NO177228C (sv)
NZ (1) NZ227384A (sv)
SE (1) SE503174C2 (sv)
SG (1) SG99494G (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
PT789580E (pt) 1994-11-03 2002-09-30 Novartis Ag Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) * 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
CZ295207B6 (cs) 1997-01-30 2005-06-15 Novartis Ag Tvrdá želatinová tobolka obsahující cyklosporin A
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AU2005209201B2 (en) 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
UA113627C2 (xx) * 2011-05-27 2017-02-27 Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування
WO2013074616A1 (en) * 2011-11-15 2013-05-23 Allergan, Inc. Autoclavable suspensions of cyclosporin a form 2
ES2666191T3 (es) 2011-11-15 2018-05-03 Allergan, Inc. Un proceso para la cristalización de la forma 2 de la ciclosporina A
US8785394B2 (en) 2011-11-15 2014-07-22 Allergan, Inc. Sustained action formulation of cyclosporin form 2
ES2791751T3 (es) * 2011-11-15 2020-11-05 Allergan Inc Suspensiones de forma 2 de ciclosporina A
WO2024085235A1 (ja) * 2022-10-20 2024-04-25 中外製薬株式会社 環状ペプチドの結晶の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (sv) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
IL88719A0 (en) 1989-07-31
BE1002665A4 (fr) 1991-04-30
IE62006B1 (en) 1994-12-14
FI89065B (fi) 1993-04-30
SG99494G (en) 1994-10-28
FR2624863A1 (fr) 1989-06-23
SE503174C2 (sv) 1996-04-15
JPH01211598A (ja) 1989-08-24
CH677926A5 (sv) 1991-07-15
GB2211848A (en) 1989-07-12
FI885869A (fi) 1989-06-22
FI885869A0 (fi) 1988-12-19
HK102894A (en) 1994-09-30
AU626274B2 (en) 1992-07-30
LU87409A1 (fr) 1989-07-07
SE8804570D0 (sv) 1988-12-19
DK705488D0 (da) 1988-12-19
FI89065C (sv) 1993-09-30
IT8848690A0 (it) 1988-12-20
KR100188305B1 (ko) 1999-06-01
KR890009975A (ko) 1989-08-05
DK705488A (da) 1989-06-22
GR1002486B (el) 1996-12-09
NO177228C (no) 1995-08-09
NO885625D0 (no) 1988-12-19
FR2624863B1 (fr) 1991-04-26
IE883779L (en) 1989-06-21
DE3843054C2 (de) 2003-08-21
NL195096C (nl) 2004-02-09
DK175220B1 (da) 2004-07-12
GB2211848B (en) 1991-11-06
NO177228B (no) 1995-05-02
JPH0791316B2 (ja) 1995-10-04
NO885625L (no) 1989-06-22
AT403163B (de) 1997-11-25
HUT49893A (en) 1989-11-28
CY1799A (en) 1995-02-17
ES2012580A6 (es) 1990-04-01
NZ227384A (en) 1991-09-25
GB8829556D0 (en) 1989-02-08
ATA309588A (de) 1997-04-15
NL8803125A (nl) 1989-07-17
MY103943A (en) 1993-10-30
DE3843054A1 (de) 1989-07-27
AU2705588A (en) 1989-06-22
GR880100850A (el) 1994-03-31
HU203564B (en) 1991-08-28
CA1341396C (en) 2002-11-05
IT1235356B (it) 1992-06-30

Similar Documents

Publication Publication Date Title
SE8804570L (sv) Ciclosporinkristallform, foerfarande foer dess framstaellning, farmaceutiska kompositioner innehaallande densamma samt dess anvaendning
EG18379A (en) Novel pharmacological compounds
UA26855C2 (uk) Фармацевтичhа композиція, яка регулює гематопоез
PH31617A (en) Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
MY101791A (en) New benzimidazole derivatives
DK0493480T3 (da) Dehydrodidemnin B
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
GEP20022636B (en) 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2
AU532114B2 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids
UA35574C2 (uk) Похідні заміщеної гетероциклом фенілциклогексанкарбонової кислоти, суміші їх ізомерів або окремі ізомери та їх солі
MY100816A (en) Skin care compositions
DK1167354T3 (da) Racemisk huperzin A
MY102929A (en) Aqueous pharmaceutical formulations of piroxicam monohydrate
DK354188D0 (da) Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen
BR8008818A (pt) Peptidos farmacologicamente ativos e medicamentos contendo os mesmos
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
IE870577L (en) Topical amide preparation
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
TR25423A (tr) DAHA AKTIF TüRLERI BAKIMINDAN ZENGINLESTIRILMIS SIPERMETRIN VEYA SIFLUTRIN ISOMERLERININ KARISIMLARININ HAZIRLANMASI.
UA26922C2 (uk) Похідhі сульфамідосульфоhілсечовиhи, що мають гербіцидhу активhість,та гербіцидhа композиція hа їх осhові
SE8704049D0 (sv) Novel pharmacological compounds
SU1450438A1 (ru) Состав для полирования монокристаллов
NO922392L (no) 6-formyl-1,3-dioksan-4-eddiksyreforbindelse, fremgangsmaate til fremstilling derav samt mellomprodukt til anvendelseved fremgangsmaaten

Legal Events

Date Code Title Description
NUG Patent has lapsed